Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01267032 · ClinicalTrials.gov registry record · Phase 2
Helping Veterans Quit Smoking by Improving Their Sleep
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- Phase 2
- Development phase
- 142
- Enrollment target
NCT01267032: Clinical Trial Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT01267032 is a Phase 2 study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 142 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01267032, a Phase 2 study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 142 participants
- Enrollment target
Study Summary
This project is designed to determine whether an efficacious behavioral intervention for insomnia can improve the quit rates achieved by an efficacious smoking cessation program aimed at PTSD patients ("Integrated Care"). A second aim is to deepen our understanding of the mechanisms relating sleep and smoking in PTSD.
Interventions
- BEHAVIORAL Integrated Care
- BEHAVIORAL Desensitization Treatment for Insomnia
- BEHAVIORAL Cognitive-Behavioral Treatment for Insomnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Why NCT01267032 stopped before completion
NCT01267032 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Integrated Care is the first listed.
NCT01267032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01267032 about?
NCT01267032 is a clinical study titled "Helping Veterans Quit Smoking by Improving Their Sleep". This project is designed to determine whether an efficacious behavioral intervention for insomnia can improve the quit rates achieved by an efficacious smoking cessation program aimed at PTSD patients ("Integrated Care"). A second aim is to deepen our understanding of the mechanisms relating sleep a...
What is the current status of trial NCT01267032?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 2011-10. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01267032?
The interventions under investigation include: Integrated Care (BEHAVIORAL), Desensitization Treatment for Insomnia (BEHAVIORAL), Cognitive-Behavioral Treatment for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT01267032?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01267032's enrollment target sits among peer trials
142 507th of 2000 higher than 1,491 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia